What happened
Shares of Insys Therapeutics (NASDAQ:INSY) rose 11% in June, according to data provided by S&P Global Market Intelligence. While the biotech is most famous for its opioid painkiller Subsys as well as Syndros, which is based on a compound in marijuana, it was clinical trial data from a new product that has investors excited.
So what
In the clinical trial, Insys’ epinephrine nasal spray had similar bioavailability as intramuscular injection with Mylan’s (NASDAQ:MYL) EpiPen, which also delivers epinephrine to treat anaphylaxis after exposure to something the patient is extremely allergic to.
The data was only from an early-stage study in 60 patients, but since both drugs use the same active ingredient, the key question was whether Insys could deliver the drug through the nose safely; once the drug is in the bloodstream, the efficacy of epinephrine should be similar.
Insys didn’t release any quantitative data from the trial, so investors will have to wait for the results to be presented at a medical conference or published in a peer-reviewed journal to see how “similar” the two delivery methods really are.
Top 5 Medical Stocks To Invest In Right Now: Officemax Incorporated(OMX)
Advisors’ Opinion:
- [By Logan Wallace]
Shivom (CURRENCY:OMX) traded down 12.7% against the U.S. dollar during the 24-hour period ending at 13:00 PM E.T. on September 26th. Shivom has a market cap of $3.56 million and approximately $42,709.00 worth of Shivom was traded on exchanges in the last day. In the last seven days, Shivom has traded down 8.3% against the U.S. dollar. One Shivom token can now be purchased for $0.0062 or 0.00000095 BTC on popular cryptocurrency exchanges including CoinBene, Kucoin, Coinsuper and IDEX.
- [By Logan Wallace]
Shivom (CURRENCY:OMX) traded 3.2% higher against the US dollar during the 24-hour period ending at 23:00 PM E.T. on September 13th. One Shivom token can currently be purchased for about $0.0069 or 0.00000105 BTC on popular exchanges including Kucoin, CoinBene, Coinsuper and DDEX. During the last week, Shivom has traded 3.3% lower against the US dollar. Shivom has a total market capitalization of $3.93 million and $74,531.00 worth of Shivom was traded on exchanges in the last day.
Top 5 Medical Stocks To Invest In Right Now: Xplore Technologies Corp(XPLR)
Advisors’ Opinion:
- [By Logan Wallace]
A10 Networks (NYSE: ATEN) and Xplore Technologies (NASDAQ:XPLR) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.
- [By Max Byerly]
Get a free copy of the Zacks research report on Xplore Technologies (XPLR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Chris Lange]
Xplore Technologies Corp. (NASDAQ: XPLR) shares spiked on Thursday after it was announced that the company would be acquired by Zebra Technologies Corp. (NASDAQ: ZBRA). The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2018.
- [By Logan Wallace]
Xplore Technologies (NASDAQ: XPLR) is one of 25 publicly-traded companies in the “Computer & office equipment” industry, but how does it compare to its peers? We will compare Xplore Technologies to related businesses based on the strength of its dividends, profitability, earnings, risk, valuation, analyst recommendations and institutional ownership.
Top 5 Medical Stocks To Invest In Right Now: Capital Trust, Inc.(BXMT)
Advisors’ Opinion:
- [By Joseph Griffin]
JMP Securities restated their hold rating on shares of Blackstone Mortgage Trust (NYSE:BXMT) in a research report sent to investors on Sunday.
A number of other analysts have also weighed in on the company. Deutsche Bank lowered Blackstone Mortgage Trust from a buy rating to a hold rating and lowered their target price for the company from $35.00 to $34.50 in a research note on Wednesday, February 13th. ValuEngine lowered Blackstone Mortgage Trust from a buy rating to a hold rating in a research note on Tuesday, February 12th. Finally, Zacks Investment Research lowered Blackstone Mortgage Trust from a buy rating to a hold rating in a research note on Tuesday, December 25th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $34.63.
- [By Motley Fool Transcribers]
Blackstone Mortgage Trust Inc (NYSE:BXMT)Q4 2018 Earnings Conference CallFeb. 13, 2019, 10:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By WWW.GURUFOCUS.COM]
For the details of Delphi Financial Group Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Delphi+Financial+Group+Inc
These are the top 5 holdings of Delphi Financial Group IncTwo Harbors Investment Corp (TWO) – 3,751,809 shares, 23.18% of the total portfolio. Energy Transfer Equity LP (ETE) – 2,979,000 shares, 20.1% of the total portfolio. Shares added by 91.45%Energy Transfer Partners LP (ETP) – 2,690,074 shares, 20.02% of the total portfolio. TPG Specialty Lending Inc (TSLX) – 1,482,024 shares, 10.4% of the total portfolio. Shares added by 4.83%Blackstone Mortgage Trust Inc (BXMT) – 773,226 shares, 9.5% of the total portfolio. Shares added b
Top 5 Medical Stocks To Invest In Right Now: iShares Core S&P Total US Stock Mkt (ITOT)
Advisors’ Opinion:
- [By Shane Hupp]
Traders purchased shares of iShares S&P 1500 Index Fund (BMV:ITOT) on weakness during trading hours on Wednesday. $50.39 million flowed into the stock on the tick-up and $29.44 million flowed out of the stock on the tick-down, for a money net flow of $20.95 million into the stock. Of all equities tracked, iShares S&P 1500 Index Fund had the 33rd highest net in-flow for the day. iShares S&P 1500 Index Fund traded down ($0.14) for the day and closed at $62.27
- [By Todd Shriber, ETF Professor]
Hundreds of exchange traded funds offer investors broad market exposure and many do so with nominal fees. Among the least expensive is the iShares Core S&P Total U.S. Stock Market ETF (NYSE: ITOT).
Top 5 Medical Stocks To Invest In Right Now: Ace Limited(ACE)
Advisors’ Opinion:
- [By Max Byerly]
Ace (CURRENCY:ACE) traded 3.5% lower against the US dollar during the 24-hour period ending at 22:00 PM ET on February 19th. Over the last week, Ace has traded up 2.4% against the US dollar. One Ace token can now be bought for approximately $0.12 or 0.00001606 BTC on exchanges. Ace has a market capitalization of $1.15 million and $364,742.00 worth of Ace was traded on exchanges in the last 24 hours.
- [By Ethan Ryder]
Ace (CURRENCY:ACE) traded down 3.5% against the U.S. dollar during the 1 day period ending at 22:00 PM E.T. on September 13th. Over the last seven days, Ace has traded 2.4% higher against the U.S. dollar. Ace has a total market capitalization of $1.15 million and $364,742.00 worth of Ace was traded on exchanges in the last day. One Ace token can currently be bought for $0.12 or 0.00001606 BTC on major exchanges.
- [By Ethan Ryder]
Ace (CURRENCY:ACE) traded 3.5% lower against the US dollar during the 1-day period ending at 21:00 PM E.T. on March 1st. Ace has a market capitalization of $1.15 million and $364,742.00 worth of Ace was traded on exchanges in the last day. One Ace token can currently be purchased for $0.12 or 0.00001606 BTC on cryptocurrency exchanges. Over the last week, Ace has traded up 2.4% against the US dollar.
- [By Joseph Griffin]
ACE (TokenStars) (CURRENCY:ACE) traded 10.1% higher against the dollar during the twenty-four hour period ending at 21:00 PM ET on October 13th. One ACE (TokenStars) token can currently be purchased for approximately $0.0571 or 0.00000912 BTC on exchanges. ACE (TokenStars) has a market capitalization of $666,377.00 and $320,387.00 worth of ACE (TokenStars) was traded on exchanges in the last day. Over the last seven days, ACE (TokenStars) has traded 19.7% lower against the dollar.
- [By Joseph Griffin]
Ace (CURRENCY:ACE) traded down 7.8% against the US dollar during the 24-hour period ending at 17:00 PM ET on July 9th. One Ace token can currently be bought for approximately $0.12 or 0.00001856 BTC on major cryptocurrency exchanges. Ace has a market capitalization of $1.15 million and $205,611.00 worth of Ace was traded on exchanges in the last 24 hours. During the last seven days, Ace has traded down 0.4% against the US dollar.